Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Frontiers in Neuroscience|June 8, 2017
DNA Methylation Changes in Intron 1 of Triggering Receptor Expressed on Myeloid Cell 2 in Japanese Schizophrenia SubjectsYuta Yoshino, Yuki Ozaki, Kiyohiro Yamazaki, et al.
Acta Neurologica Scandinavica|October 30, 2019
DRD2 methylation to differentiate dementia with Lewy bodies from Parkinson's diseaseYuki Ozaki, Yuta Yoshino, Kiyohiro Yamazaki, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|August 9, 2017
Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil TreatmentYuta Yoshino, Takaaki Mori, Taku Yoshida, et al.
Neuropsychopharmacology Reports|December 23, 2024
Association Between Stress-Induced Weight Loss and Autophagy-Related Gene Expression in the Hippocampus and Midbrain of Depression Model MiceHiroaki Mori, Yuta Yoshino, Mariko Okano, et al.
BMC Genomics|April 21, 2021
Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey methodYuta Yoshino, Hiroshi Kumon, Takaaki Mori, et al.
Journal of Neuroinflammation|May 1, 2021
Identification of aberrant innate and adaptive immunity based on changes in global gene expression in the blood of adults with autism spectrum disorderFumie Horiuchi, Yuta Yoshino, Hiroshi Kumon, et al.
BMC Neurology|June 19, 2012
Phenotypical difference of amyloid precursor protein (APP) V717L mutation in Japanese familyMasao Abe, Naomi Sonobe, Ryuji Fukuhara, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 30, 2007
Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depressionJun-Ichi Iga, Shu-Ichi Ueno, Ken Yamauchi, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|December 18, 2013
[A case report of early-onset Alzheimer's disease with multiple psychotic symptoms, finally diagnosed as APPV717I mutation by genetic testing]Takashi Ishimaru, Shinichiro Ochi, Teruhisa Matsumoto, et al.
Neuropsychopharmacology Reports|December 7, 2023
Practical clinical guidelines and pharmacological treatment for attention-deficit hyperactivity disorder in AsiaKentaro Kawabe, Fumie Horiuchi, Yu Matsumoto, et al.
Pageof 17